함께 비교하는 진짜 ADC · Antibody · CGT 데이터

CGTBiologicstaleSun Yat-Sen Memorial Hospital o…Phase 1

TCR-T therapy (TCR-T therapy)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+2

효능 ORR 4%임상시험 1상태 RECRUITING

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

KK-LC-1 TCR (KK-LC-1 TCR)

Kita-kyushu Lung Cancer Antigen 1, Human · Kita-kyushu Lung Cancer Antigen 1, Human

#Kita-kyushuLungCancerAntigen1Hum#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleThe Affiliated Hospital of Qing…Phase 1

SCG142 TCR-T cells (SCG142 TCR-T cells)

Human Papillomavirus Associated Carcinomas; Cervical Cancer · Human Papillomavirus Associated Carcinom

#HumanPapillomavirusAssociatedCar#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleAnhui Provincial HospitalPhase 1

QH101 (Allogeneic TCR-enhanced γδ T cell, Allogeneic TCR-enhanced γδ T cell(QH101))

MDS; AML · MDS

#MDS#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleGuenther KoehnePhase 1

T-cell Receptor α/β Depleted Donor Lymphocyte Infusions (T-cell Receptor α/β Depleted Donor Lymphocyte Infusions)

Lymphoid Leukemia, Acute; Myeloid Malignancy · Lymphoid Leukemia, Acute

#LymphoidLeukemiaAcute#CGT#Phase1#세포유전치료#CAR-T+5

CGTBiologicstaleCell Medica LtdPhase 2

Autologous WT1 TCR transduced T cells (Autologous WT1 TCR transduced T cells)

Myelodysplastic Syndromes (MDS); Acute Myeloid Leukaemia (AML) · Myelodysplastic Syndromes (MDS)

#MyelodysplasticSyndromesMDS#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

E7 TCR cells (E7 TCR cells)

Papillomavirus Infections; Cervical Intraepithelial Neoplasia · Papillomavirus Infections

#PapillomavirusInfections#CGT#Phase2#세포유전치료#CAR-T+3

효능 ORR 5%임상시험 1상태 ACTIVE

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Multi-epitope (ME, Multi-epitope, Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine)

Prostatic Neoplasms; Prostate Cancer · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

효능 ORR 2.4%임상시험 1상태 DISCONTINUED

CGTBiologicstaleUniversity of California, San F…Phase 1

Autologous Anti-H3.3K27M TCR-expressing T-cells (Autologous Anti-H3.3K27M TCR-expressing T-cells)

Diffuse Midline Glioma, H3 K27M-Mutant · Diffuse Midline Glioma, H3 K27M-Mutant

#DiffuseMidlineGliomaH3K27M-Mutan#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleShanghai Cell Therapy Research …Phase 2

anti-CTLA-4/PD-1 expressing EGFR-CAR-T (anti-CTLA-4/PD-1 expressing EGFR-CAR-T)

Advanced Solid Tumor · EGFR

#EGFR#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleSun Yat-sen UniversityPhase 1

LMP2 Antigen-specific TCR T cells (LMP2 Antigen-specific TCR T cells)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

Almonertinib/Furmonertinib/Osimertinib (third-generation EGFR TKIs, third-generation EGFR TKIs (Almonertinib/Furmonertinib/Osimertinib))

Non Small Cell Lung Cancer; ERBB2 Mutation-Related Tumors · EGFR

#EGFR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

T-cell receptor alternate reading frame protein (TARP, T-cell receptor alternate reading frame protein, T-cell receptor alternate reading frame protein (TARP) peptide vaccine)

Prostate Specific Antigens; Prostate Neoplasms · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleChinese PLA General HospitalPhase 2

TCR reserved and Power3 (SPPL3, TCR reserved and Power3, TCR reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T cell)

Acute Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3

AntibodystaleImmunocore LtdPhase 3

pembrolizumab (Keytruda, Tebentafusp with Pembrolizumab)

Advanced Melanoma · Advanced Melanoma

#AdvancedMelanoma#Antibody#Phase3#항체#면역항체+2

CGTBiologicstaleUniversity of PennsylvaniaPhase 1

RNA anti-CD19 CAR T cells (RNA anti-CD19 CAR T cells)

Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleShanghai Pudong HospitalPhase 1

IX001 TCR-T cells (IX001 TCR-T cells)

Pancreatic Cancer; Colorectal Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleFred Hutchinson Cancer CenterPhase 1

Autologous Mesothelin-specific TCR-T Cells (Autologous Mesothelin-specific TCR-T Cells)

Metastatic Pancreatic Ductal Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 · Metastatic Pancreatic Ductal Adenocarcin

#MetastaticPancreaticDuctalAdenoc#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleWashington University School of…Phase 2

TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft (TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft)

AML, Childhood; Aml · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5

AntibodystaleSWOG Cancer Research NetworkPreclinical

Rilotumumab (Rilotumumab)

Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC v7 · Recurrent Squamous Cell Lung Carcinoma

#RecurrentSquamousCellLungCarcino#Antibody#Preclinical#항체#면역항체+3

효능 ORR 21%임상시험 1상태 ACTIVE

CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-dNPM1-TCR.1 (MB-dNPM1-TCR.1)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#CGT#Phase2#세포유전치료#CAR-T+5

CGTBiologicstaleUniversity of Wisconsin, MadisonPhase 1

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC, TCRαβ+/CD19+ depleted Hematopoietic stem cell, TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft)

Blood Disease · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleUniversity of PennsylvaniaPhase 1

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Relapsed or Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3